AR105507A1 - LORLATINIB FREE BASE CRYSTAL FORM - Google Patents
LORLATINIB FREE BASE CRYSTAL FORMInfo
- Publication number
- AR105507A1 AR105507A1 ARP160102288A ARP160102288A AR105507A1 AR 105507 A1 AR105507 A1 AR 105507A1 AR P160102288 A ARP160102288 A AR P160102288A AR P160102288 A ARP160102288 A AR P160102288A AR 105507 A1 AR105507 A1 AR 105507A1
- Authority
- AR
- Argentina
- Prior art keywords
- free base
- crystal form
- base crystal
- lorlatinib free
- lorlatinib
- Prior art date
Links
Abstract
Reivindicación 1: Una forma cristalina de base libre de (10R)-7-amino-12-fluoro-2,10,16-trimetil-15-oxo-10,15,16,17-tetrahidro-2H-8,4-(meteno)pirazolo[4,3-h][2,5,11]benzoxadiazaciclotetradecina-3-carbonitrilo (lorlatinib), que tiene un patrón de difracción de rayos X de polvo (PXRD) que comprende dos o más picos en valores 2q seleccionados del grupo que consta de: 9.6, 10.1, 14.3, 16.2 y 17.3 º2q ± 0.2 º2q.Claim 1: A free base crystalline form of (10R) -7-amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8.4- (methane) pyrazolo [4,3-h] [2,5,11] benzoxadiazacyclotetradecin-3-carbonitrile (lorlatinib), which has a powder X-ray diffraction pattern (PXRD) comprising two or more peaks at 2q values selected from the group consisting of: 9.6, 10.1, 14.3, 16.2 and 17.3 º2q ± 0.2 º2q.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562199418P | 2015-07-31 | 2015-07-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR105507A1 true AR105507A1 (en) | 2017-10-11 |
Family
ID=60244680
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP160102288A AR105507A1 (en) | 2015-07-31 | 2016-07-27 | LORLATINIB FREE BASE CRYSTAL FORM |
Country Status (1)
Country | Link |
---|---|
AR (1) | AR105507A1 (en) |
-
2016
- 2016-07-27 AR ARP160102288A patent/AR105507A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12018500343A1 (en) | Heterocyclic amides as kinase inhibitors | |
BR112017002594A2 (en) | tank binding kinase inhibitor compounds | |
PH12016501813A1 (en) | 1,3-benzodioxole derivative | |
PL3577110T3 (en) | 8-oxetan-3-yl-3,8-diazabicyclo[3.2.1]octan-3-yl substituted compounds as hiv inhibitors | |
ECSP20025899A (en) | COMPOUNDS USEFUL TO INHIBIT CDK7 | |
GEP20197011B (en) | Heteroaryl compounds for kinase inhibition | |
MY192059A (en) | Heterocyclic amides as kinase inhibitors | |
MA39749A (en) | Piperidine-dione derivatives | |
WO2016011390A8 (en) | Irak4 inhibiting agents | |
WO2014052563A3 (en) | Novel compounds that are erk inhibitors | |
WO2016044556A3 (en) | Arginine methyltransferase inhibitors and uses thereof | |
BR112016006319A2 (en) | irak inhibitors and uses thereof | |
EA201691194A1 (en) | RHC STIMULATORS | |
AR091959A1 (en) | SYNTHETIC SUSTAINABLE AGENTS AND MONODISPERSE SUSTAINABLE AGENTS AND METHODS FOR THE ELABORATION OF THE SAME | |
GEP20186933B (en) | Substituted dihydroisoquinoline compounds | |
EA201890820A1 (en) | NEW PYRROLO [2,3-d] PYRIMIDINE DERIVATIVES AS DYRK1 / CLK1 DUAL INHIBITORS | |
EA201591805A1 (en) | OXABICICLO [2.2.2] ACIDS - MODULATORS GPR120 | |
MX2016012451A (en) | 8-(piperazin-1-yl)-1,2,3,4-tetrahydro-isoquinoline derivatives. | |
WO2014153495A9 (en) | Novel stat3 inhibitors | |
IL271399A (en) | Methods for the preparation of 1,3-benzodioxole heterocyclic compounds | |
AR103444A1 (en) | CRYSTAL FORM OF A BENCIMIDAZOL DERIVATIVE AND A METHOD OF PREPARATION OF THE SAME | |
PH12015502122A1 (en) | Sovaprevir polymorphs and methods of manufacturing thereof | |
TW201612165A (en) | Preparation method for aromatic heterocyclic compound used as selective jak3 and/or jak1 kinase inhibitor and application of aromatic heterocyclic compound | |
MX2015013048A (en) | A crystalline form of an anxiolytic compound. | |
MX2016016127A (en) | Crystal forms. |